# A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants

> **NCT06441318** · PHASE1 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 128 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Povorcitinib
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT06441318
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-12
- **Primary completion:** 2024-09-10
- **Final completion:** 2024-09-10
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441318, "A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06441318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*